Back

Evidence from international clinical trials in patients with chronic kidney disease (CKD) and type 2 diabetes

31 August 2024 (12:47 - 12:59)
Organised by: Logo
Congress Presentation Part of: A new era in the management of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and cardiovascular complications Chronic Kidney Disease Open Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Peter Rossing

Steno Diabetes Center, Copenhagen, Herlev (Denmark)

5 More presentations in this session

Presentation thumbnail
Introduction
Professor K. Marx-Schuett (Aachen, DE)
Slides Video
Presentation thumbnail
Addressing unmet needs in patients with chronic kidney disease (CKD) and type 2 diabetes
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
Foundational pillars of guideline-directed medical therapy (GDMT) across international guidelines in CKD and type 2 diabetes
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Slides Video
Presentation thumbnail
Panel discussion
Professor K. Marx-Schuett (Aachen, DE)
Video
Presentation thumbnail
Conclusion
Professor B. Bozkurt (Houston, US)
Slides Video

Access the full session

Session thumbnail
A new era in the management of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and cardiovascular complications
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 12:47 CET
You may be interested in
thumbnail
Congress Presentation
Towards the cure of CKD in T2DM: are we ready to implement four foundational therapies? - pro
thumbnail
Congress Presentation
Improving chronic kidney disease outcomes in diabetes
thumbnail
Congress Session
A new era in the management of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and cardiovascular complications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources